Articles From: Green Dot Updates 2014 Financial Outlook to Cubist Announces Continued Global Expansion with Opening of International Headquarters in Zurich


Green Dot Corporation (NYSE:GDOT) announced that it is revising its 2014 financial outlook based on the acquisition of Santa Barbara Tax Products Group (“TPG”), which was announced today, and updated year-to-date trends in the Company's core business.
Sign-up for Green Dot Updates 2014 Financial Outlook investment picks
Green Dot Corporation (NYSE:GDOT) announced today that it has entered into a definitive agreement to acquire Santa Barbara Tax Products Group (“TPG”) for approximately $320 million in cash and stock plus potential additional contingent consideration.
Sign-up for Green Dot to Acquire Santa Barbara Tax Products Group - America’s Largest Consumer Tax Refund Transaction Processor investment picks
GNCC Capital, Inc. (OTC:GNCP) (“The Company”) confirmed in a press release on September 2, 2014 that it is in discussions with various parties on further acquisitions, any one of these, which if concluded, would materially improve existing revenues and profits.
Sign-up for GNCC Capital, Inc. Clarifies on Its Immediate Term Acquisitions investment picks
The new Machine to Machine (M2M) worldwide geolocation offering from Orange Business Services (NYSE:ORAN) (Paris:ORA) provides real-time location tracking of corporate assets and equipment anywhere in the world via cellular networks, regardless of the operator.
Sign-up for Orange Business Services Launches Worldwide Location Services for Machine to Machine SIM Cards investment picks
Investment Leverages Docupace Solutions to Provide Financial Advisors with Streamlined New Business Processing, Client On-Boarding and Document Storage and Retrieval Solutions NEW YORK , Sept.
Sign-up for RCS Capital Acquires Majority Interest In Docupace Technologies investment picks
IHS Inc. (NYSE: IHS), the leading global source of information and analytics, today reported results for the third quarter ended August 31, 2014.
Sign-up for IHS Inc. Reports Third Quarter 2014 Results investment picks
2014/9/18
Population and Wealth of U.S. High Net Worth Individuals Reaches Record Levels as Wealth Creation Expands Beyond East and West Coasts Canada NewsWire New U.S. Wealth Report reveals wealth in technology and energy-centric cities is on the rise NEW YORK , MINNEAPOLIS , Sept.
Sign-up for Population and Wealth of U.S. High Net Worth Individuals Reaches Record Levels as Wealth Creation Expands Beyond East and West Coasts investment picks
2014/9/18
New U.S. Wealth Report reveals wealth in technology and energy-centric cities is on the rise NEW YORK , MINNEAPOLIS , Sept.
Sign-up for Population and Wealth of U.S. High Net Worth Individuals Reaches Record Levels as Wealth Creation Expands Beyond East and West Coasts investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G022053-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/17/11G022053/vivus-724787991482.jpg MOUNTAIN VIEW, CA and CHESTERBROOK, PA--(Marketwired - September 18, 2014) - VIVUS, Inc. (NASDAQ: VVUS) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for STENDRA ® (avanafil). STENDRA is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.
Sign-up for VIVUS and Auxilium Announce FDA Approval of STENDRA sNDA; STENDRA Now First and Only Oral Erectile Dysfunction Treatment Approved to Be Taken Approximately 15 Minutes Before Sexual Activity investment picks
PLYMOUTH MEETING, Pa.
Sign-up for Inovio to Present at Upcoming Investor Conferences investment picks
Marchex, Inc .
Sign-up for Marchex Updates 2014 Guidance investment picks
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that it has reached the halfway mark for total enrollment in the second pivotal phase 3 trial of plecanatide in patients with chronic idiopathic constipation (CIC). The trial is currently being conducted at 180 sites and has randomized over 675 CIC patients.
Sign-up for Synergy Pharmaceuticals Reaches Halfway Mark for Second Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation investment picks
2014/9/18
Penn West Announces Conference Call Details to Discuss its Results for the Second Quarter Ended June 30, 2014 Canada NewsWire CALGARY , Sept.
Sign-up for Penn West Announces Conference Call Details to Discuss its Results for the Second Quarter Ended June 30, 2014 investment picks
2014/9/18
By Neetha Mahadevan and Ulrike Dauer FRANKFURT--Germany's Merck KGaA (MRK.XE) on Thursday said it's in talks with potential global partners to jointly develop and market an immuno-oncology drug, and it plans to extend its partnerships in India and Brazil in its biosimilars business.
Sign-up for Merck KGaA: In Talks With Potential Partners to Develop Immuno-Oncology Drug investment picks
2014/9/18
By Laura He, MarketWatch HONG KONG (MarketWatch) -- Following a positive lead from U.S. markets overnight, Japanese stocks rose to an eight-month closing high on Thursday, as the yen hit a six-year low against the greenback, aiding export-related stocks.
Sign-up for ASIA MARKETS: Japanese Stocks Climb To Eight-month Closing High investment picks
2014/9/18
By Laura He, MarketWatch HONG KONG (MarketWatch) -- Following a positive lead from U.S. markets overnight, Japanese stocks rose to an eight-month closing high on Thursday, as the yen hit a six-year low against the greenback, aiding export-related stocks.
Sign-up for Japanese stocks climb to eight-month closing high investment picks
By Howard Gold, MarketWatch Lots of people will do very, very well when Alibaba Group Holding's shares start trading on the New York Stock Exchange on Friday.
Sign-up for UPDATE: China's favorite sons will score big in Alibaba IPO investment picks
2014/9/18
By Philip van Doorn, MarketWatch We are living in the Age of the Activist Investor.
Sign-up for UPDATE: 10 stocks that may soon be on activist investors' hit list investment picks
2014/9/18
Price to earnings Company Ticker Market capitalization ($bil) EBITDA margin - 2013 EBITDA margin - 2012 Margin change EPS - 2012 EPS % change General Electric Co.
Sign-up for UPDATE: 10 stocks that may soon be on activist -2- investment picks
2014/9/18
LONDON-- Shares in U.K. mobile payments technology group Monitise PLC (MONI.LN) slumped nearly 30% after the U.S. payments giant Visa Inc. (V) said it is considering its options over its 5.5% stake in the company.
Sign-up for Monitise Shares Slide As Visa Assesses Stake investment picks
As Taylor Consulting, Inc. (OTCBB:TAYO) and its real estate division, Third Avenue Development, continue to build a competitive portfolio of assets in West Texas, economic indicators in the region remain overwhelmingly positive.
Sign-up for TAYO: Texas Oil Boom Continues as Production Increases Nearly 30 Percent investment picks
2014/9/18
By Alex MacDonald LONDON--Shares in U.S. focused oil and gas company Magnolia Petroleum PLC (MAGP.LN) fell 5% Thursday after the company announced the initial flow rate from a well in the Mississippi lime formation in Oklahoma.
Sign-up for Magnolia Shares Fall After Unveiling Cummings 2nd Half Well Output Rate investment picks
2014/9/18
ZURICH--The Swiss National Bank repeated Thursday that it will intervene in the foreign exchange market to prevent the Swiss franc from surpassing 1.20 against the euro, saying the limit remains the "key instrument" to curb upward pressure on the currency.
Sign-up for Swiss National Bank Reaffirms Currency Floor investment picks
2014/9/18
With resistant bacterial infections resulting in an estimated 25,000 deaths in the European Union and 23,000 deaths in the United States annually, the issues of rising antibiotic resistance and the lack of treatment options have raised alarms with world leaders.
Sign-up for Cubist Announces Continued Global Expansion with Opening of International Headquarters in Zurich investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Green Dot Updates 2014 Financial Outlook to Cubist Announces Continued Global Expansion with Opening of International Headquarters in Zurich
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices